PARP Inhibitor Biomarkers Market Advances with Focus on Ovarian...

agregó una foto Other

2025-07-04 07:30:40 -

PARP Inhibitor Biomarkers Market Advances with Focus on Ovarian Cancer Care

The global PARP inhibitor biomarkers market size was estimated at USD 904.10 million in 2023 and is projected to reach USD 1,602.10 million by 2030, expanding at a CAGR of 8.54% from 2024 to 2030. This growth is primarily driven by the increasing prevalence of breast cancer, significant advancements in genetic technologies, and rising expenditures on oncology treatments. As reported...

0 Commentarios 0 Acciones 35 Views 0 Vista previa